NovaQuest closes pharmaceutical fund on $459m

A 2010 spin-out out of pharmaceutical services company Quintiles, NovaQuest had targeted $500m for its Fund III.

ByChelsea Stevenson

7 November 2013•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Managers North America